Trial · NCT01289821
Adverse events110
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
101 to 110 of 110
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| serious | Skin infection | Infections and infestations | Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6) | 1 | 53 | 1 |
| serious | Dehydration | Metabolism and nutrition disorders | Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6) | 1 | 53 | 1 |
| serious | Hypokalemia | Metabolism and nutrition disorders | Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6) | 1 | 53 | 1 |
| serious | Dizziness | Nervous system disorders | Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6) | 1 | 53 | 1 |
| serious | Neoplasms benign, malignant and unspecified (incl cysts and polyps) - Other, specify | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6) | 1 | 53 | 1 |
| serious | Tumor pain | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6) | 1 | 53 | 1 |
| serious | Skin and subcutaneous tissue disorders - Other, specify | Skin and subcutaneous tissue disorders | Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6) | 1 | 53 | 1 |
| serious | Surgical and medical procedures - Other, specify | Surgical and medical procedures | Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6) | 7 | 53 | 9 |
| serious | Hypertension | Vascular disorders | Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6) | 1 | 53 | 1 |
| serious | Thromboembolic event | Vascular disorders | Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6) | 3 | 53 | 3 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01289821/events?page=6